Mechanisms of amyloid-β clearance in models of vascular cognitive impairment and mixed dementia 

Gabor Petzold (Germany) and Danica Stanimirovic (Canada)

Perturbation of cerebral blood flow and the blood brain barrier are prominent features of Alzheimer's disease. The central hypothesis of this project is that these changes directly affect the transport of amyloid-β, a peptide centrally involved in AD initiation and progression, across the blood brain barrier, leading to increased accumulation of amyloid-β in the brain. We aim to identify the molecular mechanisms responsible for this imbalance of amyloid-β trafficking in mouse models of AD, vascular dementia and mixed dementia (i.e. vascular dementia and AD). Finally, we will also investigate whether pharmacological intervention specifically targeting Aβ trafficking can be therapeutically beneficial in these models.

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: